Table 1. Baseline characteristics of study participants.
Placebo | Simvastatin & Niacin | Antioxidant vitamins | Simvastatin, Niacin & Anitoxidant vitamins | |
Males (N)/Females (N) | 30/2 | 28/5 | 34/4 | 33/6 |
Age | 52.9±7.7 | 52.6±9.4 | 53.8±8.3 | 54.9±7.5 |
BMI (kg/m2) | 29.7±3.9 | 29.3±4.0 | 28.7±3.4 | 29.9±4.9 |
Current Smokers (%) | 18.8 | 24.2 | 26.3 | 23.1 |
LDL-peak (nm) | 25.53±0.13 | 25.74±0.13 | 25.51±0.12 | 25.68±0.12 |
LDL-I (mmol/L) | 0.44±0.05 | 0.50±0.05 | 0.37±0.05 | 0.44±0.05 |
LDL-IIa (mmol/L) | 0.46±0.06 | 0.54±0.06 | 0.37±0.05 | 0.47±0.05 |
LDL-IIb (mmol/L) | 0.73±0.06 | 0.74±0.06 | 0.64±0.06 | 0.71±0.06 |
LDL-IIIa (mmol/L) | 0.58±0.06 | 0.57±0.05 | 0.63±0.05 | 0.59±0.05 |
LDL-IIIb (mmol/L) | 0.18±0.02 | 0.13±0.02 | 0.15±0.02 | 0.15±0.02 |
LDL-IVa (mmol/L) | 0.12±0.01 | 0.12±0.01 | 0.11±0.01 | 0.11±0.01 |
LDL-IVb (mmol/L) | 0.11±0.01 | 0.11±0.01 | 0.11±0.01 | 0.11±0.01 |
LDL-C (mmol/L) | 3.28±0.13 | 3.38±0.13 | 3.06±0.12 | 3.20±0.12 |
HDL-C (mmol/L) | 0.82±0.02 | 0.82±0.02 | 0.83±0.02 | 0.78±0.02 |
Triglycerides (mmol/L) | 2.22±0.20 | 2.27±0.20 | 2.38±0.19 | 2.66±0.18 |
Age and BMI are displayed as mean±SD, lipoproteins as means±SE